FDA Brief

Company record

Novo Nordisk Inc.

2 FDA warning letters since 2023 and 2 recalls in the last 12 months.

Get an email the day FDA posts anything new about Novo Nordisk Inc..

Warning letters

  1. Novo Nordisk Inc.

    FDA warns Novo Nordisk over failures to report and investigate serious unexpected adverse drug experiences for drugs including semaglutide.

    High risk
  2. Novo Nordisk Inc.

    FDA says Novo Nordisk’s Oprah Winfrey video makes Wegovy, Ozempic and Victoza look safer than their labels allow.

    High risk

Recalls

ReportedClassFirmProduct and reason
Jan 7 Class II Novo Nordisk Inc.
Drug
Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC…
Presence of Particulate Matter: Hair was found in a prefilled syringe
Jan 7 Class II Novo Nordisk Inc.
Drug
Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, N…
Presence of Particulate Matter: Hair was found in a prefilled syringe